Circ_0078607 increases platinum drug sensitivity via miR-196b-5p/GAS7 axis in ovarian cancer

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–13.
   PubMed Web of Science ®Google Scholar
• Martin LP, Hamilton TC, Schilder RJ. Platinum resistance: the role of DNA repair pathways. Clin Cancer Res. 2008;14(5):1291–1295.
   PubMed Web of Science ®Google Scholar
• Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007;33(1):9–23.
   PubMed Web of Science ®Google Scholar
• Syrios J, Banerjee S, Kaye SB. Advanced epithelial ovarian cancer: from standard chemotherapy to promising molecular pathway targets–where are we now? Anticancer Res. 2014;34(5):2069–2077.
   PubMed Web of Science ®Google Scholar
• Ryu J, Thomas SN. Quantitative mass spectrometry-based proteomics for biomarker development in ovarian cancer. Molecules. 2021;26:9.
   Web of Science ®Google Scholar
• Elzek MA, Rodland KD. Proteomics of ovarian cancer: functional insights and clinical applications. Cancer Metastasis Rev. 2015;34(1):83–96.
   PubMed Web of Science ®Google Scholar
• Xueyuan H, Qianru C, Zhaoyi L, et al. Transcriptome analysis reveals that hydrogen sulfide exposure suppresses cell proliferation and induces apoptosis through ciR-PTPN23/miR-15a/E2F3 signaling in broiler thymus. Environ Pollut. 2021;284:117466.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Ji M, Wang Q, et al. RNA Cdr1as upregulates SCAI to suppress cisplatin resistance in ovarian cancer via miR-1270 suppression. Mol Ther Nucleic Acids. 2019;18:24–33.
   PubMedGoogle Scholar
• Luo Y, Gui R. Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells. J Gynecol Oncol. 2020;31(5):e75.
   PubMed Web of Science ®Google Scholar
• Zhang N, Jin Y, Hu Q, et al. Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway. J Ovarian Res. 2020;13(1):64.
   PubMed Web of Science ®Google Scholar
• Zhang N, Yang Z, Jin Y, et al. Low expression of circular RNA hsa_circ_0078607 predicts poor prognosis in high-grade serous ovarian cancer. Cancer Manag Res. 2021;13:2877–2883.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Bao C, Guo W, et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016;7:11215.
   PubMed Web of Science ®Google Scholar
• Yang C, Dong Z, Hong H, et al. circFN1 mediates sorafenib resistance of hepatocellular carcinoma cells by sponging miR-1205 and regulating E2F1 expression. Mol Ther Nucleic Acids. 2020;22:421–433.
   PubMedGoogle Scholar
• Liu G, Zhang Z, Song Q, et al. Circ_0006528 contributes to paclitaxel resistance of breast cancer cells by regulating miR-1299/CDK8 axis. Onco Targets Ther. 2020;13:9497–9511.
   PubMed Web of Science ®Google Scholar
• Xin H, Wang C, Chi Y, et al. MicroRNA-196b-5p promotes malignant progression of colorectal cancer by targeting ING5. Cancer Cell Int. 2020;20:119.
   PubMed Web of Science ®Google Scholar
• Liang G, Meng W, Huang X, et al. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer. Proc Natl Acad Sci U S A. 2020;117(8):4347–4357.
   PubMed Web of Science ®Google Scholar
• Dong Z, Yeo KS, Lopez G, et al. GAS7 deficiency promotes metastasis in MYCN-driven neuroblastoma. Cancer Res. 2021;81(11):2995–3007.
   PubMed Web of Science ®Google Scholar
• Ping W, Gao Y, Fan X, et al. MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7. Biochem Biophys Res Commun. 2018;495(4):2482–2489.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhang Y, Gao J, et al. Circular RNAs act as regulators of autophagy in cancer. Mol Ther Oncolytics. 2021;21:242–254.
   PubMed Web of Science ®Google Scholar
• Kong F, Lv Z, Wang L, Zhang K, Cai Y, Ding Q, et al. RNA-sequencing of peripheral blood circular RNAs in Parkinson disease. Medicine (Baltimore). 2021;100(23):e25888.
   PubMed Web of Science ®Google Scholar
• Tan M, Bei R. Circ_0091702 serves as a sponge of miR-545-3p to attenuate sepsis-related acute kidney injury by upregulating THBS2. J Mol Histol. 2021;52(4):717–728 .
   PubMed Web of Science ®Google Scholar
• Samavarchi Tehrani S, Goodarzi G, Panahi G, et al. Multiple novel functions of circular RNAs in diabetes mellitus. Arch Physiol Biochem. 2021 Jun 4:1–30.
   Google Scholar
• Duan L, Yan Y, Wang G, et al. MuiR-182-5p functions as a tumor suppressor to sensitize human ovarian cancer cells to cisplatin through direct targeting the cyclin dependent kinase 6 (CDK6). J BUON. 2020;25(5):2279–2286.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li L, Zhang W, et al. Circular RNA circLDB2 functions as a competing endogenous RNA to suppress development and promote cisplatin sensitivity in non-squamous non-small cell lung cancer. Thorac Cancer. 2021;12(13):1959–1972.
   Google Scholar
• Sun Y, Ma J, Lin J. Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis. Anticancer Drugs. 2021;32(9):950–961.
   PubMed Web of Science ®Google Scholar
• Cui X, Wang J, Guo Z, et al. Emerging function and potential diagnostic value of circular RNAs in cancer. Mol Cancer. 2018;17(1):123.
   PubMedGoogle Scholar
• Li Y, Zhang Y, Zhang S, et al. circRNA circARNT2 suppressed the sensitivity of hepatocellular carcinoma cells to cisplatin by targeting the miR-155-5p/PDK1 axis. Mol Ther Nucleic Acids. 2021;23:244–254.
   PubMedGoogle Scholar
• Bao Y, Zhang Y, Lu Y, et al. Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition. Int J Biol Sci. 2020;16(5):827–837.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang J, Chen P, et al. MicroRNA-320a inhibits invasion and metastasis in osteosarcoma by targeting cytoplasmic polyadenylation element-binding protein 1. Cancer Med. 2020;9(8):2833–2845.
   PubMed Web of Science ®Google Scholar
• Xu Q, Xu Z. miR-196b-5p promotes proliferation, migration and invasion of lung adenocarcinoma cells via targeting RSPO2. Cancer Manag Res. 2020;12:13393–13402.
   PubMedGoogle Scholar
• Wu F, Yin C, Qi J, et al. miR-362-5p promotes cell proliferation and cell cycle progression by targeting GAS7 in acute myeloid leukemia. Hum Cell. 2020;33(2):405–415.
   PubMed Web of Science ®Google Scholar